首页> 外国专利> METHOD AND COMPOSITION FOR ENDOGENOUS PRODUCTION OF CONSTITUTIVELY ACTIVATED RECEPTORS, AND RECEPTORS WITH BROADER BINDING RANGES OR HIGHER AFFINITY THAN NATIVE RECEPTORS

METHOD AND COMPOSITION FOR ENDOGENOUS PRODUCTION OF CONSTITUTIVELY ACTIVATED RECEPTORS, AND RECEPTORS WITH BROADER BINDING RANGES OR HIGHER AFFINITY THAN NATIVE RECEPTORS

机译:用于内源性活化受体的内源性产生的方法和组合物,以及具有比本地受体更高的结合范围或更高的亲和力的受体

摘要

The present disclosure relates to one or more agents, therapies, treatments, and methods of use of the agents and/or therapies and/or treatments for upregulating the production of one or more receptors proteins that are constitutively activated, or have broader binding ranges or higher affinity than native receptors. Embodiments of the present disclosure can be used as a therapy or a treatment for a subject that has a condition whereby the subject's receptor-ligand system is, or is likely to become, dysregulated and wherein the upregulation of these proteins may be of therapeutic benefit.
机译:本公开涉及一种或多种试剂,治疗,处理和使用方法和/或治疗方法,用于上调构成型活化的一种或多种受体蛋白的产生,或具有更广泛的结合范围或比本土受体更高的亲和力。本公开的实施方案可以用作具有该受试者的受试者的受试者的受试者的治疗或治疗,其中受试者的受体 - 配体系是,并且可能使得这些蛋白质的上调可能具有治疗益处。

著录项

  • 公开/公告号US2021087582A1

    专利类型

  • 公开/公告日2021-03-25

    原文格式PDF

  • 申请/专利权人 DELORS PHARMA INC.;

    申请/专利号US201916580996

  • 发明设计人 BRADLEY G. THOMPSON;

    申请日2019-09-24

  • 分类号C12N15/86;C12N7;A61K35/76;A61K48;A61K38/17;

  • 国家 US

  • 入库时间 2022-08-24 17:54:42

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号